drugset
drugset / Trial / NCT01689116

Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

NCT01689116 ↗

Phase 1 Completed 179 enrolled Biogen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-center, multiple-dose, randomized, double-blind, double-dummy, placebo-controlled, active-comparator, parallel study in healthy volunteers.

Timeline

Start
2012-08-31
Primary completion
2012-11-30
Completion
2012-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bardoxolone methyl Small molecule 20 mg Oral
Subject Bardoxolone methyl Small molecule 80 mg Oral
Comparator Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.